Abstract: The present invention provides compositions and methods relating to or derived from antigen binding proteins activate FGF21-mediated signaling. In embodiments, the antigen binding proteins specifically bind to (i) ?-Klotho; (ii) FGFR1c, FGFR2c, FGFR3c or FGFR4; or (iii) a complex comprising ?-Klotho and one of FGFR1c, FGFR2c, FGFR3c, and FGFR4. In some embodiments the antigen binding proteins induce FGF21-like signaling. In some embodiments, an antigen binding protein is a fully human, humanized, or chimeric antibodies, binding fragments and derivatives of such antibodies, and polypeptides that specifically bind to (i) ?-Klotho; (ii) FGFR1c, FGFR2c, FGFR3c or FGFR4; or (iii) a complex comprising ?-Klotho and one of FGFR1c, FGFR2c, FGFR3c, and FGFR4.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen binding protein to PCSK9 are described.

Abstract: The photostability of organic material is enhanced by the incorporation of a plurality of particles which may for example have a diameter of 0.03 microns to 2.5 microns. The organic material may be a light absorbing material and may be photoluminescent or electroluminescent. Compositions in accordance with the invention incorporating an electroluminescent material of enhanced photostability may be used in an Organic Light Emitting Diode (OLED).

Abstract: A photorefractive composite comprises a charge transport matrix and an electrooptic dye having an aliphatic group of four or more carbon atoms.

Abstract: A solid surface is coated with an adhesive composition comprising an aromatic polysulphone which has a reduced viscosity of at least 0.3 and which contains at least 0.2 (desirably 0.5 to 3.5) hydroxyl groups per 100 polymer repeat units and has been heated at 330.degree. C to 450.degree. C in the presence of oxygen.

Abstract: A novel amorphous thermoplastic aromatic polysulphone is provided consisting of repeating units having the formula ##STR1##

Abstract: A solid surface is coated with an adhesive composition comprising an aromatic polysulphone which has a reduced viscosity of at least 0.3 and which contains at least 0.2 (desirably 0.5 to 3.5) hydroxyl groups per 100 polymer repeat units and has been heated at 330.degree. to 450.degree.C in the presence of oxygen.

Abstract: An aromatic polymer comprising recurring units having the formula --Ar--Q-- is made by a new process which comprises heating an alkali metal fluoride with an activated halophenol of the formula X--Ar--QH and/or a substantially equimolar mixture of an activated dihalobenzenoid compound of the formula X--Ar--X and a dihydric phenol of the formula HQ--Ar--QH in which formulae Ar and Q are respectively a bivalent aromatic residue and an oxygen or sulphur atom and may vary from unit to unit in the polymer chain and X is a halogen atom, the amount of alkali metal fluoride being such that together with any of the X atoms that are fluorine the total number of fluorine atoms in the reaction system is at least twice the number of --QH groups in the system.